exact sciences corp. - EXAS
EXAS
Close Chg Chg %
103.92 0.99 0.95%
Closed Market
104.91
+0.99 (0.95%)
Volume: 21.56M
Last Updated:
Mar 20, 2026, 4:00 PM EDT
Company Overview: exact sciences corp. - EXAS
EXAS Key Data
| Open $104.93 | Day Range 104.90 - 104.98 |
| 52 Week Range 38.88 - 104.98 | Market Cap N/A |
| Shares Outstanding NaN | Public Float N/A |
| Beta N/A | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS N/A |
| Yield N/A | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 3.49M |
EXAS Performance
| 1 Week | 0.00% | ||
| 1 Month | 1.48% | ||
| 3 Months | 3.29% | ||
| 1 Year | 140.29% | ||
| 5 Years | -16.74% |
EXAS Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
An error occurred while fetching the data.
SEC Filings for Exact Sciences Corp. - EXAS
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Exact Sciences Corp. - EXAS
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 5, 2026 | Sarah Condella EVP, Human Resources | 133,034 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $5.03 per share | 669,161.02 |
| Mar 5, 2026 | Sarah Condella EVP, Human Resources | 131,121 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $103.38 per share | 13,555,288.98 |
| Mar 5, 2026 | Sarah Condella EVP, Human Resources | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 18, 2025 | Aaron Bloomer EVP, Chief Financial Officer | 11,556 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 18, 2025 | Aaron Bloomer EVP, Chief Financial Officer | 6,436 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.25 per share | 284,793.00 |
| Apr 18, 2025 | Aaron Bloomer EVP, Chief Financial Officer | 19,340 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 18, 2025 | Aaron Bloomer EVP, Chief Financial Officer | 13,623 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.25 per share | 602,817.75 |
| Apr 18, 2025 | Aaron Bloomer EVP, Chief Financial Officer | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 18, 2025 | Aaron Bloomer EVP, Chief Financial Officer | 38,715 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |